BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

262 related articles for article (PubMed ID: 17442573)

  • 1. Shedding light on Merlin's wizardry.
    Okada T; You L; Giancotti FG
    Trends Cell Biol; 2007 May; 17(5):222-9. PubMed ID: 17442573
    [TBL] [Abstract][Full Text] [Related]  

  • 2. NF2: the wizardry of merlin.
    Xiao GH; Chernoff J; Testa JR
    Genes Chromosomes Cancer; 2003 Dec; 38(4):389-99. PubMed ID: 14566860
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inactivation of the NF2 tumor suppressor protein merlin in DU145 prostate cancer cells.
    Horiguchi A; Zheng R; Shen R; Nanus DM
    Prostate; 2008 Jun; 68(9):975-84. PubMed ID: 18361411
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cell cycle-dependent nucleocytoplasmic shuttling of the neurofibromatosis 2 tumour suppressor merlin.
    Muranen T; Grönholm M; Renkema GH; Carpén O
    Oncogene; 2005 Feb; 24(7):1150-8. PubMed ID: 15580288
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization of the NF2 protein merlin and the ERM protein ezrin in human, rat, and mouse central nervous system.
    Grönholm M; Teesalu T; Tyynelä J; Piltti K; Böhling T; Wartiovaara K; Vaheri A; Carpén O
    Mol Cell Neurosci; 2005 Apr; 28(4):683-93. PubMed ID: 15797715
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inactivation of Merlin in malignant mesothelioma cells and the Hippo signaling cascade dysregulation.
    Sekido Y
    Pathol Int; 2011 Jun; 61(6):331-44. PubMed ID: 21615608
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Merlin/neurofibromatosis type 2 suppresses growth by inhibiting the activation of Ras and Rac.
    Morrison H; Sperka T; Manent J; Giovannini M; Ponta H; Herrlich P
    Cancer Res; 2007 Jan; 67(2):520-7. PubMed ID: 17234759
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of merlin phosphorylation on neurofibromatosis 2 (NF2) gene function.
    Surace EI; Haipek CA; Gutmann DH
    Oncogene; 2004 Jan; 23(2):580-7. PubMed ID: 14724586
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Phosphorylation status of merlin is important for regulating the Ras-ERK pathway.
    Jung JR; Kim H; Jeun SS; Lee JY; Koh EJ; Ji C
    Mol Cells; 2005 Oct; 20(2):196-200. PubMed ID: 16267393
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Protein kinase A-mediated phosphorylation of the NF2 tumor suppressor protein merlin at serine 10 affects the actin cytoskeleton.
    Laulajainen M; Muranen T; Carpén O; Grönholm M
    Oncogene; 2008 May; 27(23):3233-43. PubMed ID: 18071304
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Akt phosphorylation regulates the tumour-suppressor merlin through ubiquitination and degradation.
    Tang X; Jang SW; Wang X; Liu Z; Bahr SM; Sun SY; Brat D; Gutmann DH; Ye K
    Nat Cell Biol; 2007 Oct; 9(10):1199-207. PubMed ID: 17891137
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Subcellular localization and expression pattern of the neurofibromatosis type 2 protein merlin/schwannomin.
    Schmucker B; Ballhausen WG; Kressel M
    Eur J Cell Biol; 1997 Jan; 72(1):46-53. PubMed ID: 9013725
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evolution and origin of merlin, the product of the Neurofibromatosis type 2 (NF2) tumor-suppressor gene.
    Golovnina K; Blinov A; Akhmametyeva EM; Omelyanchuk LV; Chang LS
    BMC Evol Biol; 2005 Dec; 5():69. PubMed ID: 16324214
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neurofibromatosis 2 tumor suppressor, the gene induced by valproic acid, mediates neurite outgrowth through interaction with paxillin.
    Yamauchi J; Miyamoto Y; Kusakawa S; Torii T; Mizutani R; Sanbe A; Nakajima H; Kiyokawa N; Tanoue A
    Exp Cell Res; 2008 Jul; 314(11-12):2279-88. PubMed ID: 18486129
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tumor-suppression functions of merlin are independent of its role as an organizer of the actin cytoskeleton in Schwann cells.
    Lallemand D; Saint-Amaux AL; Giovannini M
    J Cell Sci; 2009 Nov; 122(Pt 22):4141-9. PubMed ID: 19910496
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cellular transformation by a FERM domain mutant of the Nf2 tumor suppressor gene.
    Johnson KC; Kissil JL; Fry JL; Jacks T
    Oncogene; 2002 Sep; 21(39):5990-7. PubMed ID: 12203111
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Angiomotin binding-induced activation of Merlin/NF2 in the Hippo pathway.
    Li Y; Zhou H; Li F; Chan SW; Lin Z; Wei Z; Yang Z; Guo F; Lim CJ; Xing W; Shen Y; Hong W; Long J; Zhang M
    Cell Res; 2015 Jul; 25(7):801-17. PubMed ID: 26045165
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The tumor suppressor merlin interacts with microtubules and modulates Schwann cell microtubule cytoskeleton.
    Muranen T; Grönholm M; Lampin A; Lallemand D; Zhao F; Giovannini M; Carpén O
    Hum Mol Genet; 2007 Jul; 16(14):1742-51. PubMed ID: 17566081
    [TBL] [Abstract][Full Text] [Related]  

  • 19. NF2 deficiency promotes tumorigenesis and metastasis by destabilizing adherens junctions.
    Lallemand D; Curto M; Saotome I; Giovannini M; McClatchey AI
    Genes Dev; 2003 May; 17(9):1090-100. PubMed ID: 12695331
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Contact-dependent inhibition of EGFR signaling by Nf2/Merlin.
    Curto M; Cole BK; Lallemand D; Liu CH; McClatchey AI
    J Cell Biol; 2007 Jun; 177(5):893-903. PubMed ID: 17548515
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.